116 related articles for article (PubMed ID: 38323632)
1. Proposal for Prognosis-Oriented Definition of Borderline Resectable Hepatocellular Carcinoma.
Haruki K; Harimoto N; Furukawa K; Taniai T; Yanagaki M; Igarashi Y; Tsunematsu M; Shirai Y; Shirabe K; Ikegami T
J Am Coll Surg; 2024 Jun; 238(6):1137-1147. PubMed ID: 38323632
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
3. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
4. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
[TBL] [Abstract][Full Text] [Related]
5. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
[No Abstract] [Full Text] [Related]
7. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
[TBL] [Abstract][Full Text] [Related]
8. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.
Ma KW; She WH; Cheung TT; Chan ACY; Dai WC; Fung JYY; Lo CM; Chok KSH
Surg Today; 2019 Jun; 49(6):521-528. PubMed ID: 30637484
[TBL] [Abstract][Full Text] [Related]
9. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
10. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
13. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
[TBL] [Abstract][Full Text] [Related]
14. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.
Zhu WJ; Huang CY; Li C; Peng W; Wen TF; Yan LN; Li B; Wang WT; Xu MQ; Yang JY; Jiang L
Asian Pac J Cancer Prev; 2013; 14(12):7101-6. PubMed ID: 24460258
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of major hepatectomy for large hepatocellular carcinoma.
Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
[TBL] [Abstract][Full Text] [Related]
19. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]